Longevity
Montana takes next step on experimental therapies
Rules for SB 535 are now in place, clearing the way for review boards and treatment centers to begin evaluating post-Phase 1 therapies. After more than a year of anticipation, Montana’s most closely watched longevity law has moved from legislation to implementation. Montana’s ambitious effort to reshape access to experimental medicine has reached a new […] The post Montana takes next step on experimental therapies appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →